Wednesday, August 18, 2021

Inhibitor drug entinostat ‘primes’ the body to better respond to anti-cancer treatment with immunotherapy

Combining a histone deacetylase inhibitor drug with immunotherapy agents has been deemed safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial.

from Top Health News -- ScienceDaily https://ift.tt/3geELbz
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Study finds untreated sleep apnea doubles Parkinson’s risk

A massive veteran study found a strong connection between untreated sleep apnea and a higher chance of Parkinson’s. CPAP users had much lowe...